CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Long-Term Assessment of Safety and Therapeutic Benefit of Viaskin® Peanut Epicutaneous Treatment in Peanut-Allergic Children: A 6-Month Randomized, Double-Blind, Placebo-Controlled Phase III Study Followed by an Open-Label Active Treatment (REALISE Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02916446
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-10-09T00:07:47.169094+00:00
Published At: 2026-10-08T00:00:00+00:00
Record Updated At: 2026-10-08
Results Posted At: 2026-10-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Peanut Allergy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-10-08"
protocolSection.identificationModule.nctId: "NCT02916446"
protocolSection.identificationModule.officialTitle: "Long-Term Assessment of Safety and Therapeutic Benefit of Viaskin\u00ae Peanut Epicutaneous Treatment in Peanut-Allergic Children: A 6-Month Randomized, Double-Blind, Placebo-Controlled Phase III Study Followed by an Open-Label Active Treatment (REALISE Study)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-10-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.